Etilevodopa HCl (TV-1203; Levodopa ethyl ester; L-Dopa ethyl ester; O-Ethyl-DOPA), the hydrochloride salt of Etilevodopa, is a dopaminergic agent used for the treatment for Parkinson’s disease.

Etilevodopa (TV-1203; Levodopa ethyl ester; L-Dopa ethyl ester; O-Ethyl-DOPA) is a dopaminergic agent used for the treatment for Parkinson’s disease.

Brexpiprazole (formerly OPC-34712; OPC34712; Rexulti) is a novel D2 dopamine partial agonist [also called serotonin-dopamine activity modulator (SDAM)] approved as an atypical antipsychotic drug.

Oxidopamine hydrobromide (6-OHDA hydrobromide; 6-OHDA HBr) is a neurotoxin acting as a dopamine antagonist and destroying catecholaminergic terminals.

Sultopride Hydrochloride is a selective D2 and D3 receptor antagonist.

Diclofensine HCl salt (also known as Ro-8-4650 HCl) is a novel and potent inhibitor of monoamine reuptake which blocks the uptake of dopamine, noradrenaline, and serotonin by rat brain synaptosomes with IC50 values of 0.74, 2.3, and 3.7 nM, respectively. Diclofensine is used as an antidepressant with equipotent inhibitive effects on the neuronal uptake of […]